1. Açık Erişim@BUU
  2. İndeksli Yayınlar
  3. Web of Science
Bu öğeden alıntı yapmak, öğeye bağlanmak için bu tanımlayıcıyı kullanınız: http://hdl.handle.net/11452/28980
Tüm üstveri kaydı
Dublin Core AlanıDeğerDil
dc.date.accessioned2022-10-06T05:50:06Z-
dc.date.available2022-10-06T05:50:06Z-
dc.date.issued2007-03-30-
dc.identifier.citationSivrioğlu, E. Y. vd. (2007). "Reboxetine induced erectile dysfunction and spontaneous ejaculation during defecation and micturition". Progress in Neuro-Psychopharmacology & Biological Psychiatry, 31(2), 548-550.en_US
dc.identifier.issn0278-5846-
dc.identifier.issn1878-4216-
dc.identifier.urihttps://doi.org/10.1016/j.pnpbp.2006.10.006-
dc.identifier.urihttps://www.sciencedirect.com/science/article/pii/S0278584606003848-
dc.identifier.urihttp://hdl.handle.net/11452/28980-
dc.description.abstractThis is a case report of reboxetine induced erectile dysfunction, seminal emission and ejaculation during defecation and micturition. A 44 year old male who had been suffering from depression without any sexual dysfunction was put on venlafaxine XR treatment. Due to delayed ejaculation and occasional episodes of absence of ejaculation he was switched to reboxetine. At the second week of treatment he reported erectile dysfunction and premature ejaculation, and seminal emission and ejaculation during defecation and micturition occurred later at 8th week of treatment. After he was switched to sertraline 50 mg/day, his erectile dysfunction, premature and spontaneous ejaculation symptoms subsided in 2 weeks. Although reboxetine is reported to be free of sexual side effects, individual vulnerabilities to such unwanted effects should be considered, and sexual dysfunction should be assessed thoroughly during the treatment.en_US
dc.language.isoenen_US
dc.publisherPergamon-Elsevier Scienceen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectReboxetineen_US
dc.subjectErectile dysfunctionen_US
dc.subjectPremature ejaculationen_US
dc.subjectSexual dysfunctionen_US
dc.subjectSpontaneous ejaculationen_US
dc.subjectInduced sexual dysfunctionen_US
dc.subjectAntidepressantsen_US
dc.subjectPharmacologyen_US
dc.subjectDisordersen_US
dc.subjectSerotoninen_US
dc.subject.meshAdulten_US
dc.subject.meshDefecationen_US
dc.subject.meshMorpholinesen_US
dc.subject.meshAntidepressive agentsen_US
dc.subject.meshHumansen_US
dc.subject.meshDepressive disorder, majoren_US
dc.subject.meshMaleen_US
dc.subject.meshSexual and gender disordersen_US
dc.subject.meshUrinationen_US
dc.titleReboxetine induced erectile dysfunction and spontaneous ejaculation during defecation and micturitionen_US
dc.typeArticleen_US
dc.identifier.wos000244808800039tr_TR
dc.identifier.scopus2-s2.0-33846818587tr_TR
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergitr_TR
dc.contributor.departmentUludağ Üniversitesi/Tıp Fakültesi/Psikiyatri Bölümü.tr_TR
dc.identifier.startpage548tr_TR
dc.identifier.endpage550tr_TR
dc.identifier.volume31tr_TR
dc.identifier.issue2tr_TR
dc.relation.journalProgress in Neuro-Psychopharmacology & Biological Psychiatryen_US
dc.contributor.buuauthorSivrioğlu, Enver Yusuf-
dc.contributor.buuauthorTopaloğlu, Veli Cihat-
dc.contributor.buuauthorSarandöl, Aslı-
dc.contributor.buuauthorAkkaya, Cengiz-
dc.contributor.buuauthorEker, Salih Saygın-
dc.contributor.buuauthorKırlı, Selçuk-
dc.contributor.researcheridQ-9477-2019tr_TR
dc.identifier.pubmed17123681tr_TR
dc.subject.wosClinical neurologyen_US
dc.subject.wosPsychiatryen_US
dc.subject.wosPharmacology & pharmacyen_US
dc.subject.wosNeurosciencesen_US
dc.indexed.wosSCIEen_US
dc.indexed.scopusScopusen_US
dc.indexed.pubmedPubMeden_US
dc.wos.quartileQ2en_US
dc.contributor.scopusid14062563200tr_TR
dc.contributor.scopusid15840726600tr_TR
dc.contributor.scopusid14020405100tr_TR
dc.contributor.scopusid14061855100tr_TR
dc.contributor.scopusid14019347700tr_TR
dc.contributor.scopusid14019745700tr_TR
dc.subject.scopusSexual; Serotonin Uptake Inhibitors; Libido Disorderen_US
dc.subject.emtreeReboxetineen_US
dc.subject.emtreeDepressionen_US
dc.subject.emtreePenis erectionen_US
dc.subject.emtreeSertralineen_US
dc.subject.emtreeVenlafaxineen_US
dc.subject.emtreeAdulten_US
dc.subject.emtreeArticleen_US
dc.subject.emtreeCase reporten_US
dc.subject.emtreeDefecationen_US
dc.subject.emtreeDrug withdrawalen_US
dc.subject.emtreeSymptomatologyen_US
dc.subject.emtreeDrug dose increaseen_US
dc.subject.emtreeDrug substitutionen_US
dc.subject.emtreeMaleen_US
dc.subject.emtreeMajor depressionen_US
dc.subject.emtreeEjaculation disorderen_US
dc.subject.emtreeErectile dysfunctionen_US
dc.subject.emtreeHamilton scaleen_US
dc.subject.emtreeHumanen_US
dc.subject.emtreeMicturitionen_US
dc.subject.emtreePremature ejaculationen_US
dc.subject.emtreeRemissionen_US
dc.subject.emtreeTreatment outcomeen_US
Koleksiyonlarda Görünür:PubMed
Scopus
Web of Science

Bu öğenin dosyaları:
Bu öğeyle ilişkili dosya bulunmamaktadır.
Kısa Öğe Kaydını Göster İstatistikler


DSpace'deki bütün öğeler, aksi belirtilmedikçe, tüm hakları saklı tutulmak şartıyla telif hakkı ile korunmaktadır.